![Financial regulation / Cardiology / Lipoproteins / Apolipoprotein A1 / Apolipoproteins / Atheroma / High-density lipoprotein / AstraZeneca / Atherosclerosis / Circulatory system / Medicine / Health Financial regulation / Cardiology / Lipoproteins / Apolipoprotein A1 / Apolipoproteins / Atheroma / High-density lipoprotein / AstraZeneca / Atherosclerosis / Circulatory system / Medicine / Health](https://www.pdfsearch.io/img/6edb35c7a44cdad1a772b74daf0547b7.jpg)
| Document Date: 2014-08-01 10:58:15 Open Document File Size: 921,08 KBShare Result on Facebook
Company Resverlogix Corp. / Citibank / Zenith Epigenetics Corp. / Resverlogix Inc. / RVX Therapeutics Inc. / / Country United States / Canada / / Currency USD / CAD / / Event M&A / Debt Financing / Patent Issuance / Funding / General or Shareholder Meeting / Reorganization / Business Partnership / Dividend Issuance / Company Expansion / Second Stock Issuance / / IndustryTerm business development services / pharmaceutical agent / insurance charges / manufacturing / site management / / MedicalCondition disease / percent atheroma volume / cardiovascular disease / coronary atherosclerosis / atheroma / diseases / / Organization Alberta Securities Commission / ded / / Person Adverse Cardiac / / Position investigator / director / Major / General and Administrative General / Private / / Product Crestor / Lipitor / RVX-208 / / ProvinceOrState Alberta / / Technology pharmacokinetics / drug metabolism / gene expression / ATM / 208 technology / drug development / CAD / /
SocialTag |